Concerns about FTD diagnosis in Aruba are receiving new attention after the Alzheimer’s Foundation Aruba described difficulties that some patients and families face when seeking clear answers about neurocognitive disorders.
Foundation president and neuropsychologist Melva Croes-Yánez addressed the issue during an event held in connection with International Alzheimer’s Day. She said the organization supports people affected by a range of neurocognitive conditions, not only Alzheimer’s disease, and drew particular attention to frontotemporal dementia, or FTD.
Families report confusing assessments
According to Croes-Yánez, behavioral changes associated with FTD can be misread or attributed to other causes. She said family members who raise concerns may struggle to have those observations taken seriously, even though relatives are often the first to notice major changes in a person’s behavior.
The foundation also described cases in which an initial Alzheimer’s diagnosis was later changed to mild cognitive impairment without producing a clear overall explanation. Croes-Yánez said that this uncertainty can leave patients and relatives without a firm path forward.
Second-opinion barriers add pressure
The foundation said an unclear diagnosis can make it difficult for patients to request a second medical opinion. Croes-Yánez also reported that some families have met resistance when asking another professional to review a case.
Her message was that people in Aruba facing complex neurocognitive conditions should receive a consistent standard of care and that relatives’ concerns should be treated seriously. The statements add a patient-care dimension to local awareness efforts that have already focused on helping the public recognize frontotemporal disorders.
Source: EA News Aruba — Alzheimer’s Foundation Aruba on FTD diagnosis concerns
